IBT VACCINES
Similar Organizations
ALVA10
ALVA10 is a biotechnology service company.
Biojet
Biojet is a biofuels company.
Botany AI
Botany AI is a biotechnology company.
Circular Carbon
Circular Carbon is a Biotechnology company.
Faze Medicines
Faze Medicines is a biotechnology company.
Geneius
Geneius is a Biotechnology company.
Repertoire Genesis
Repertoire Genesis is a biotechnology company.
Sonaphi
Sonaphi is a Biotechnology Company.
Space Cargo Unlimited
Space Cargo Unlimited is a french biotech company.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Investors List
Repair Impact Fund
Repair Impact Fund investment in Venture Round - IBT Vaccines
More informations about "IBT Vaccines"
IBT Bioservices Transforms Identity, Elevates Focus on Contract ...
Apr 1, 2024 IBT Bioservices is a leading Contract Research Organization (CRO) specializing in preclinical and clinical research services within the Biocapital region. Driven by innovation and client-centricity, IBT Bioservices is dedicated to propelling the development of modern …See details»
IBT Vaccines Receives $3.9 mil. to Advance Development of IBT …
Jan 7, 2020 IBT Vaccines, a wholly owned subsidiary of Integrated Biotherapeutics Inc., announces it has received $3.9 million to advance the development of the IBT-V02 vaccine for …See details»
IBT Bioservices - LinkedIn
Accelerate your influenza vaccine research with IBT Bioservices' tailored HAI assay services. Our expertise in working with diverse antigens (live, inactivated, mouse-adapted) ensures accurate and ...See details»
In vitro Assays & Infection Models
IBT Bioservices is the services division of Integrated BioTherapeutics, Inc. (IBT). IBT Bioservices offers a range of products and services to support pre-clinical research and development of …See details»
Integrated BioTherapeutics - PMC
Integrated Biotherapeutic (IBT) was founded by Dr. M. Javad Aman as a multi-program, multi-platform company focused on discovering and developing vaccines and immunotherapeutics …See details»
Vaccine Adjuvant Screening Services | IBT
At IBT Bioservices, we are dedicated to providing you with reliable and comprehensive vaccine adjuvant screening services. Our state-of-the-art facilities, cutting-edge technologies, and …See details»
IBT Vaccines - Crunchbase Company Profile & Funding
Organization. IBT Vaccines . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. IBT Vaccines is a biotechnology company. …See details»
IBT Bioservices - Crunchbase Company Profile & Funding
IBT utilizes multiparameter flow cytometry to evaluate drug and vaccine efficacy, employing fluid systems and fluorescent proteins to detect and collect signals. Reagents and Antibodies IBT offers a range of research reagents, including …See details»
MSD CRO - IBT Bioservices | Meso Scale Discovery
IBT Bioservices is a collaborative research organization offering R&D services to identify and develop vaccines and therapeutics for infectious diseases. As experts in the field of infectious …See details»
IBT Vaccines - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jan 6, 2020: ... Venture Round …See details»
IBT-V02: A Multicomponent Toxoid Vaccine Protects Against
Mar 10, 2021 IBT-V02 targets six SA toxins including the pore-forming toxins alpha hemolysin (Hla), Panton-Valentine leukocidin (PVL), leukocidin AB (LukAB), and the superantigens toxic …See details»
Integrated Biotherapeutics Awarded $3.55M Grant to Study …
Mar 24, 2022 The Company's lead vaccine product, IBT-V02 is a first-in-class multi-component vaccine against Staphylococcus aureus. Supported by CARB-X and by Novo Holding's Repair …See details»
Full article: Integrated BioTherapeutics - Taylor & Francis Online
Apr 11, 2018 Citation 2,3 The vaccine is currently at the stage of process development and preclinical safety and efficacy testing. This vaccine is supported by NIAID and CARB-X …See details»
NEWS AND PUBLICATIONS - IBT
Nov 4, 2019 IBT Vaccines Receives $3.9 mil. to Advance Development of IBT-V02 Against MRSA. IBT Vaccines, a wholly owned subsidiary of Integrated Biotherapeutics Inc., …See details»
Integrated Biotherapeutics awarded $3.55M grant to study …
WFMZ | Study is expected to provide insights into mechanisms of protection against staph infection. IBT and its subsidiary Integrated BioTherapeutic Vaccines (IBV) are developing IBT …See details»
Integrated BioTherapeutics - Crunchbase Company Profile
Integrated BioTherapeutics is a biotechnology company that focuses on discovering novel vaccines and therapeutics for emerging infectious diseases. Its antiviral pipeline includes …See details»
Integral Molecular and Integrated BioTherapeutics Collaborate to ...
Nov 2, 2021 IBT develops vaccines and immunotherapies for bacterial and viral infectious diseases. The Company's lead vaccine product, IBT-V02 is a first-in-class multi-component …See details»
Increases in vaccine-preventable disease outbreaks threaten years …
16 hours ago Outbreaks of vaccine-preventable diseases are increasing around the world, putting lives at risk and exposing countries to increased costs in treating diseases and …See details»
Integrated BioTherapeutics - PMC - National Center for …
Apr 11, 2018 Integrated Biotherapeutic (IBT) was founded by Dr. M. Javad Aman as a multi-program, multi-platform company focused on discovering and developing vaccines and …See details»
Five Takeaways and Next Steps from the Immunization Agenda 2030
Mar 19, 2025 The recently updated Immunization Agenda 2030 (IA2030) scorecard on the World Health Organization’s (WHO’s) ... the global strategy target for 2030. The jump in HPV vaccine …See details»